98%
921
2 minutes
20
Enterohepatic circulation (EHC) is a critical biological process for the normal regulation of many endogenous biomolecules and the increased retention of various exogenous substances. The status of EHC is closely related to the ordinary functioning of several digestive organs. However, it remains a challenge to achieve in vivo real-time visualization of this process. Herein, we rationally design and synthesize a ferrous chelate, DO3A-Fe(II)-9F, with high fluorine content and favorable water solubility for visualizing EHC viaF magnetic resonance imaging (MRI). The assessments on imaging performance reveal an 18-time increase in signal intensity compared to the fluorinated ligand alone. This probe's capability of entering EHC via the mediation of organic anion transporting polypeptides (OATPs) is validated with ex vivo bio-distribution analysis and in vivo uptake-blocking imaging experiments, which allows short-time sensitive F MRI of EHC in healthy mice. Additionally, we illustrate its capacity for clearly imaging tampered EHC in the mice with inflammatory bowel diseases (IBD), drug-induced liver injury (DILI) or orthotopic hepatocellular carcinoma (HCC). These results illustrate the promising potential of this probe for in vivo visualization of EHC under different conditions, especially disease conditions, which is beneficial for the study, diagnosis, or even stratification of various diseases.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.biomaterials.2024.123073 | DOI Listing |
Drug Des Devel Ther
August 2025
Beijing Key Laboratory of Pharmacology of Chinese Materia Medica, Institute of Basic Medical Sciences, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, People's Republic of China.
Propose: Sailuotong (SLT), a standardized Chinese herbal preparation for vascular dementia (VaD), is frequently co-administered with pitavastatin (PIV). Potential herb-drug interactions (HDIs) between these agents remain uncharacterized. Given the high likelihood of using this combination to treat VaD, this study aims to systematically evaluate the effects of SLT on PIV's pharmacokinetics and elucidate underlying mechanisms.
View Article and Find Full Text PDFGut Microbes
December 2025
Department of Urology, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Gut microbial dysbiosis and the resultant metabolic disorder are intimately associated with calcium oxalate (CaOx) stone formation. Renal CaOx crystal deposition is one of the primary initiating factors of CaOx formation; however, the critical signaling metabolites communicating along the gut-kidney axis, and their regulation on renal CaOx crystal deposition remain unclear. Here, we investigate the role of gut microbiota-associated unconjugated bilirubin (UCB) metabolism in renal CaOx crystalline pathogenesis.
View Article and Find Full Text PDFToxicol Appl Pharmacol
August 2025
Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan.
Physiologically based pharmacokinetic (PBPK) modeling is a valuable approach for addressing the scarcity of human toxicokinetic data, particularly in the risk assessment of agrochemicals. While numerous PBPK models have been developed to describe various pharmacokinetics processes, modeling the complex kinetics of enterohepatic circulation remains challenging. Procymidone, a widely used fungicide, undergoes initial metabolism to hydroxylated-procymidone, an active metabolite with antiandrogenic properties, followed by glucuronidation.
View Article and Find Full Text PDFMicrobiome
August 2025
State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, 214122, P. R. China.
Background: Recent studies suggest a role of gut microbiota in the development of neonatal hyperbilirubinemia, with bifidobacteria showing promise in alleviating symptoms. However, uncertainties persist regarding gut bifidobacterial species composition and their effects on bilirubin metabolism. Therefore, the study investigated the association between the gut microbiota and neonatal hyperbilirubinemia, assessing the potential and underlying mechanisms of Bifidobacterium in managing the condition.
View Article and Find Full Text PDFFASEB J
August 2025
Department of Immunology, School of Basic Medical Sciences, Peking University. NHC Key Laboratory of Medical Immunology (Peking University), Beijing, China.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a metabolic disease characterized by excessive accumulation of liver fat, encompassing nonalcoholic fatty liver (NAFL) and metabolic dysfunction-associated steatohepatitis (MASH), which is among the rapidly proliferating diseases globally. MASLD disrupts the normal structure and function of the liver, resulting in liver fibrosis, cirrhosis, and ultimately hepatocellular cancer and other severe outcomes. Recent investigations have demonstrated that intestinal flora significantly influence the development of MASLD.
View Article and Find Full Text PDF